Previous studies have shown that PODNL1, a member of the small leucine-rich proteoglycan family, is a potential tumor matrix-mediated biomarker and is strongly associated with glioma prognosis (Geyang et al., 2023; Shanqiang et al., 2023). This evidence concerns the gene PODNL1 and central nervous system cancer.